IL315004A - : Liquid botulinum toxin formulation and its uses - Google Patents
: Liquid botulinum toxin formulation and its usesInfo
- Publication number
- IL315004A IL315004A IL315004A IL31500424A IL315004A IL 315004 A IL315004 A IL 315004A IL 315004 A IL315004 A IL 315004A IL 31500424 A IL31500424 A IL 31500424A IL 315004 A IL315004 A IL 315004A
- Authority
- IL
- Israel
- Prior art keywords
- botulinum toxin
- toxin formulation
- liquid botulinum
- liquid
- formulation
- Prior art date
Links
- 108030001720 Bontoxilysin Proteins 0.000 title 1
- 229940053031 botulinum toxin Drugs 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 239000007788 liquid Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
- A61K38/4893—Botulinum neurotoxin (3.4.24.69)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/38—Albumins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/38—Albumins
- A61K38/385—Serum albumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/66—Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/06—Anti-spasmodics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/24—Metalloendopeptidases (3.4.24)
- C12Y304/24069—Bontoxilysin (3.4.24.69), i.e. botulinum neurotoxin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Birds (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Zoology (AREA)
- Urology & Nephrology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Toxicology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22156843 | 2022-02-15 | ||
| EP22183172 | 2022-07-05 | ||
| PCT/EP2023/053647 WO2023156389A1 (en) | 2022-02-15 | 2023-02-14 | Liquid botulinum toxin formulation and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL315004A true IL315004A (en) | 2024-10-01 |
Family
ID=85202119
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL315004A IL315004A (en) | 2022-02-15 | 2023-02-14 | : Liquid botulinum toxin formulation and its uses |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20250152682A1 (https=) |
| EP (1) | EP4479023A1 (https=) |
| JP (1) | JP2025504249A (https=) |
| KR (1) | KR20240141340A (https=) |
| CN (1) | CN119031902A (https=) |
| AR (1) | AR128514A1 (https=) |
| AU (1) | AU2023221507A1 (https=) |
| CA (1) | CA3243238A1 (https=) |
| CO (1) | CO2024010940A2 (https=) |
| IL (1) | IL315004A (https=) |
| MX (1) | MX2024009970A (https=) |
| TW (1) | TW202348248A (https=) |
| WO (1) | WO2023156389A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025228877A1 (en) | 2024-04-29 | 2025-11-06 | Merz Therapeutics GmbH | Botulinum toxin for the preventive treatment of migraine |
| WO2026021713A1 (en) | 2024-07-23 | 2026-01-29 | Merz Therapeutics GmbH | Uses of magnetic nerve stimulation associated with botulinum neurotoxin administration |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7780967B2 (en) * | 2000-02-08 | 2010-08-24 | Allergan, Inc. | Reduced toxicity Clostridial toxin pharmaceutical compositions |
| US20060269575A1 (en) * | 2000-02-08 | 2006-11-30 | Allergan, Inc. | Botulinum toxin pharmaceutical compositions formulated with recombinant albumin |
| JP2006045173A (ja) * | 2004-08-09 | 2006-02-16 | Hidetoshi Tsuchida | 表面修飾血清アルブミン−金属ポルフィリン複合体、およびそれを含有する酸素輸液 |
| PT2271670E (pt) | 2008-03-14 | 2014-11-28 | Allergan Inc | Ensaio imunobaseado da atividade do serotipo a da toxina botulínica |
| CA2766649C (en) * | 2009-06-24 | 2016-08-23 | Charles N.S. Soparkar | Zinc supplementation to increase responsiveness to metalloprotease therapy |
| ES2653249T3 (es) | 2011-09-29 | 2018-02-06 | Cellsnap, Llc | Composiciones y métodos para ensayos de toxigenicidad |
| AU2014301116B2 (en) | 2013-06-28 | 2019-11-14 | Merz Pharma Gmbh & Co. Kgaa | Means and methods for the determination of the biological activity of Neurotoxin polypeptides in cells |
| PL3463432T3 (pl) * | 2016-05-27 | 2021-04-19 | Ipsen Biopharm Limited | Ciekła formulacja neurotoksyny stabilizowana tryptofanem lub tyrozyną |
-
2023
- 2023-02-14 IL IL315004A patent/IL315004A/en unknown
- 2023-02-14 US US18/838,555 patent/US20250152682A1/en active Pending
- 2023-02-14 WO PCT/EP2023/053647 patent/WO2023156389A1/en not_active Ceased
- 2023-02-14 JP JP2024547688A patent/JP2025504249A/ja active Pending
- 2023-02-14 CA CA3243238A patent/CA3243238A1/en active Pending
- 2023-02-14 KR KR1020247030641A patent/KR20240141340A/ko active Pending
- 2023-02-14 CN CN202380033828.4A patent/CN119031902A/zh active Pending
- 2023-02-14 AU AU2023221507A patent/AU2023221507A1/en active Pending
- 2023-02-14 AR ARP230100336A patent/AR128514A1/es unknown
- 2023-02-14 TW TW112105172A patent/TW202348248A/zh unknown
- 2023-02-14 EP EP23704176.9A patent/EP4479023A1/en active Pending
- 2023-02-14 MX MX2024009970A patent/MX2024009970A/es unknown
-
2024
- 2024-08-12 CO CONC2024/0010940A patent/CO2024010940A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2024009970A (es) | 2024-09-18 |
| US20250152682A1 (en) | 2025-05-15 |
| AR128514A1 (es) | 2024-05-15 |
| KR20240141340A (ko) | 2024-09-26 |
| TW202348248A (zh) | 2023-12-16 |
| CN119031902A (zh) | 2024-11-26 |
| JP2025504249A (ja) | 2025-02-06 |
| WO2023156389A1 (en) | 2023-08-24 |
| CA3243238A1 (en) | 2023-08-24 |
| EP4479023A1 (en) | 2024-12-25 |
| CO2024010940A2 (es) | 2024-09-19 |
| AU2023221507A1 (en) | 2024-08-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL315004A (en) | : Liquid botulinum toxin formulation and its uses | |
| GB202204964D0 (en) | Superpixel generatioion and use | |
| IL314995A (en) | Liquid botulinum toxin formulation and use thereof | |
| EP4382092A4 (en) | STABLE LIQUID FORMULATION CONTAINING BOTULINUM TOXIN | |
| HUE065531T2 (hu) | Enzifentrint és glikopirrolátot tartalmazó folyékony gyógyszerkészítmény | |
| GB2611153B (en) | Gate driver and display device using the same | |
| GB2578093B (en) | Liquid pharmaceutical composition comprising RPL554 and HFA-134A | |
| EP4073559A4 (en) | DISPLAY DEVICES AND ITEMS HAVING COLOR MATCHED DISPLAY AND NON-DISPLAY SURFACES | |
| IL268688B1 (en) | Improved use of botulinum toxin to treat sialorrhea | |
| PL3906016T3 (pl) | Ciekły ekstrakt z propolisu, jego preparat i zastosowania | |
| IL288531A (en) | Broad-spectrum antibacterial pharmaceutical formulations comprising lyses and methods of using them | |
| IL326140A (en) | Liquid formulation of botulinum toxin and its use | |
| EP4083097A4 (en) | COMPOSITION AND DISPLAY DEVICE | |
| IL305789A (en) | USP30 inhibitors and uses thereof | |
| CA3299476A1 (en) | Liquid botulinum toxin formulation and use thereof | |
| IL275785A (en) | Devices and methods for issuing liquids | |
| IL304528A (en) | Liquid formulation of protein and methods of its preparation | |
| EP4282400A4 (en) | ANTIMICROBIAL PEPTIDE LIQUID COMPOSITION AND FORMULATION THEREOF | |
| PL4096097T3 (pl) | Instalacja wyświetlająca i obsługowa | |
| EP3947323A4 (en) | LIQUID FERTILIZER FORMULATIONS COMPATIBLE WITH MYKORRHIZAE AND/OR BACILLUS AMYLOLIQUEFACIENS | |
| IL319382A (en) | Pharmaceutical preparation and its use | |
| ZA202212893B (en) | Medical liquid dressing and preparation method and application thereof | |
| PL3888634T3 (pl) | Preparat oftalmiczny i jego zastosowanie | |
| EP4209786A4 (en) | FLUID DEVICE AND ITS USE | |
| PL4346847T3 (pl) | Kompleks wielojonowy do stosowania w profilaktyce lub leczeniu zapalenia neurogennego |